A quantitative clinical pharmacology-based framework for model-informed vaccine development
Historically, vaccine development and dose optimization have followed mostly empirical approaches without clinical pharmacology and…
CertaraNovember 20, 2023
Key Lessons from the 2nd Annual FDA ASCO WORKSHOP on Getting the Dosage Right: Optimizing Dosage Selection Strategies in Combination Cancer Therapies
Cancer treatment has evolved from generally cytotoxic therapies towards drugs that target specific pathways and…
CertaraNovember 17, 2023
No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost
Quantitative systems pharmacology (QSP) models generate predictions by formalizing biological understanding and integrating multiscale data,…
CertaraNovember 16, 2023
The “Animal Rule” – What if a clinical trial simply isn’t ethical?
Clinical trials always pose a challenge to demonstrating a drug’s safety and efficacy. Sometimes, the…
CertaraNovember 10, 2023
Certara Reports Third Quarter 2023 Financial Results
Reiterates Full Year 2023 Financial Guidance PRINCETON, N.J.— November 8, 2023-- Certara, Inc. (Nasdaq: CERT), a…
CertaraNovember 8, 2023
Are Gaps in Your Clinical Pharmacology Program Jeopardizing Your Drug’s Approval?
Clinical pharmacology information comprises more than 50% of a drug label. Inadequate clinical pharmacology development…
CertaraNovember 7, 2023
Strategy to overcome clinical pharmacology challenges for regulatory approvals [APAC Webinar]
Clinical pharmacology information comprises more than 50% of a drug label. Inadequate clinical pharmacology development…
CertaraNovember 6, 2023
Certara Recognized as 2023 Employer of Choice
PRINCETON, N.J.— November 1 2023, Certara (Nasdaq: CERT), a global leader in biosimulation, today announced…
CertaraNovember 1, 2023
Can’t ChatGPT Do That? Practical Applications for AI in Drug Discovery & Development
Explore how Certara.AI tackles the limits of generalized GPTs like ChatGPT to transform drug discovery,…
CertaraOctober 31, 2023
